Geneos Wealth Management’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.24M | Sell |
22,996
-962
| -4% | -$303K | 0.15% | 160 |
|
|
2026
Q1 | $7.87M | Buy |
23,958
+1,626
| +7% | +$584K | 0.18% | 129 |
|
|
2025
Q4 | $7.85M | Sell |
22,332
-367
| -2% | -$134K | 0.19% | 136 |
|
|
2025
Q3 | $8.39M | Sell |
22,699
-433
| -2% | -$167K | 0.21% | 124 |
|
|
2025
Q2 | $9.15M | Buy |
23,132
+7,777
| +51% | +$2.91M | 0.22% | 111 |
|
|
2025
Q1 | $5.72M | Buy |
15,355
+1,337
| +10% | +$509K | 0.19% | 128 |
|
|
2024
Q4 | $5.05M | Buy |
14,018
+92
| +0.7% | +$34.1K | 0.18% | 133 |
|
|
2024
Q3 | $5.03M | Buy |
13,926
+262
| +2% | +$90.4K | 0.19% | 130 |
|
|
2024
Q2 | $4.65M | Buy |
13,664
+216
| +2% | +$73.2K | 0.21% | 116 |
|
|
2024
Q1 | $4.81M | Sell |
13,448
-796
| -6% | -$268K | 0.22% | 117 |
|
|
2023
Q4 | $4.27M | Sell |
14,244
-266
| -2% | -$74.7K | 0.21% | 120 |
|
|
2023
Q3 | $3.97M | Buy |
14,510
+170
| +1% | +$48.7K | 0.2% | 128 |
|
|
2023
Q2 | $4.38M | Buy |
14,340
+575
| +4% | +$166K | 0.23% | 120 |
|
|
2023
Q1 | $3.93M | Sell |
13,765
-2,043
| -13% | -$542K | 0.24% | 105 |
|
|
2022
Q4 | $3.86M | Buy |
15,808
+595
| +4% | +$135K | 0.23% | 115 |
|
|
2022
Q3 | $3.08M | Sell |
15,213
-671
| -4% | -$141K | 0.21% | 118 |
|
|
2022
Q2 | $3.24M | Buy |
15,884
+654
| +4% | +$154K | 0.16% | 147 |
|
|
2022
Q1 | $4.07M | Buy |
15,230
+1,662
| +12% | +$430K | 0.17% | 139 |
|
|
2021
Q4 | $3.63M | Buy |
13,568
+759
| +6% | +$199K | 0.14% | 163 |
|
|
2021
Q3 | $3.44M | Buy |
12,809
+647
| +5% | +$173K | 0.13% | 175 |
|
|
2021
Q2 | $3.23M | Sell |
12,162
-2,155
| -15% | -$551K | 0.13% | 181 |
|
|
2021
Q1 | $3.76M | Buy |
14,317
+1,549
| +12% | +$371K | 0.1% | 203 |
|
|
2020
Q4 | $2.82M | Buy |
12,768
+1,859
| +17% | +$421K | 0.11% | 193 |
|
|
2020
Q3 | $2.24M | Buy |
10,909
+290
| +3% | +$56.4K | 0.12% | 185 |
|
|
2020
Q2 | $1.84M | Buy |
10,619
+1,764
| +20% | +$325K | 0.1% | 197 |
|
|
2020
Q1 | $1.41M | Buy |
8,855
+6,950
| +365% | +$1.36M | 0.09% | 215 |
|
|
2019
Q4 | $401K | Buy |
1,905
+30
| +2% | +$6.23K | 0.02% | 489 |
|
|
2019
Q3 | $400K | Hold |
1,875
| – | – | 0.02% | 461 |
|
|
2019
Q2 | $385K | Sell |
1,875
-70
| -4% | -$13.4K | 0.02% | 486 |
|
|
2019
Q1 | $384K | Sell |
1,945
-149
| -7% | -$26.8K | 0.03% | 470 |
|
|
2018
Q4 | $324K | Sell |
2,094
-16
| -0.8% | -$2.68K | 0.02% | 468 |
|
|
2018
Q3 | $374K | Sell |
2,110
-172
| -8% | -$29.4K | 0.02% | 452 |
|
|
2018
Q2 | $385K | Hold |
2,282
| – | – | 0.03% | 377 |
|
|
2018
Q1 | $367K | Buy |
2,282
+288
| +14% | +$46.4K | 0.03% | 374 |
|
|
2017
Q4 | $308K | Buy |
1,994
+119
| +6% | +$18.2K | 0.03% | 418 |
|
|
2017
Q3 | $266K | Buy |
1,875
+350
| +23% | +$50.2K | 0.03% | 432 |
|
|
2017
Q2 | $211K | Hold |
1,525
| – | – | 0.02% | 486 |
|
|
2017
Q1 | $200K | Sell |
1,525
-4
| -0.3% | -$505 | 0.02% | 481 |
|
|
2016
Q4 | $183K | Hold |
1,529
| – | – | 0.02% | 474 |
|
|
2016
Q3 | $177K | Buy |
1,529
+4
| +0.3% | +$466 | 0.02% | 471 |
|
|
2016
Q2 | $183K | Hold |
1,525
| – | – | 0.03% | 461 |
|
|
2016
Q1 | $165K | Buy |
+1,525
| New | +$150K | 0.03% | 472 |
|
Other funds holding SYK
GT
Geneos Wealth Management's SYK Position: Q2 2026 in Review
Geneos Wealth Management reduced its Stryker (SYK) stake by 4% in Q2 2026, selling an estimated $303K and leaving 22,996 shares worth $7.24M. The position accounts for 0.15% of the portfolio, ranked #160.
Geneos Wealth Management first reported a position in SYK in Q1 2016 and has held it in 42 quarters since. The position peaked at $9.15M in Q2 2025. 2,266 funds tracked by Wall St. Rank hold SYK as of Q2 2026.
- Geneos Wealth Management held 22,996 shares of Stryker worth $7.24M as of Q2 2026.
- Geneos Wealth Management sold 962 Stryker shares in Q2 2026, an estimated $303K.
- Stryker made up 0.15% of Geneos Wealth Management's portfolio in Q2 2026, its #160 holding.
- Geneos Wealth Management first reported a position in Stryker in Q1 2016 and has held it in 42 quarters since.
- Geneos Wealth Management's Stryker position peaked at $9.15M in Q2 2025.
- 2,266 funds tracked by Wall St. Rank held Stryker as of Q2 2026.
Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.